Genetic polymorphisms associated with steroids metabolism and insulin action in polycystic ovary syndrome

Gynecological Endocrinology

Volumn 28, Issue 3, 2012, Pages 190-194

  Ramos Cirilo, Priscila Daniele ^a   Rosa, Fabíola Encinas ^a,b   Moreira Ferraz, Maria Fernanda ^a   Rainho, Cláudia Aparecida ^a   Pontes, Anaglória ^a   Rogatto, Silvia Regina ^a,b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

Androgen metabolism; Androgen receptor; Estrogen receptor; Infertility; Insulin resistance; Polycystic ovary syndrome

Indexed keywords

AROMATASE; INSULIN; SOMATOMEDIN B; TESTOSTERONE;

ADULT; ALLELE; AR GENE; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYP17A1 GENE; DNA EXTRACTION; ESR1 GENE; ESR2 GENE; FEMALE; GENE; GENE DELETION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PAI1 GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STEROID METABOLISM; STEROIDOGENESIS; TESTOSTERONE BLOOD LEVEL;

ADULT; AROMATASE; BRAZIL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INSULIN RESISTANCE; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, GENETIC; RECEPTOR, INSULIN; RECEPTORS, ANDROGEN; STEROID 17-ALPHA-HYDROXYLASE; STEROIDS;

EID: 84856862463     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2011.593661     Document Type: Article

References (29)

1. Farrell K, Antoni MH. Insulin resistance, obesity, infammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions. Fertil Steril 2010;94:1565-1574.
2. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-47.
3. Sharp L, Cardy AH, Cotton SC, Little J. CYP17 gene polymorphisms: prevalence and associations with hormone levels and related factors. a HuGE review. Am J Epidemiol 2004;160:729-740. (Pubitemid 39362210)
4. Ito Y, Fisher CR, Conte FA, Grumbach MM, Simpson ER. Molecular basis of aromatase defciency in an adult female with sexual infantilism and polycystic ovaries. Proc Natl Acad Sci USA 1993;90:11673-11677. (Pubitemid 24008701)
5. Ibáñez L, Ong KK, Mongan N, Jääskeläinen J, Marcos M V, Hughes IA et al. Androgen receptor gene CAG repeat polymorphism in the development of ovarian hyperandrogenism. J Clin Endocrinol Metab 2003;88:3333-3338. (Pubitemid 36877513)
6. Syrrou M, Georgiou I, Patsalis PC, Bouba I, Adonakis G, Pagoulatos GN. Fragile X premutations and (TA)n estrogen receptor polymorphism in women with ovarian dysfunction. Am J Med Genet 1999;84: 306-308. (Pubitemid 29206990)
7. Westberg L, Baghaei F, Rosmond R, Hellstrand M, Landén M, Jansson M et al. Polymorphisms of the androgen receptor gene and the estrogen receptor beta gene are associated with androgen levels in women. J Clin Endocrinol Metab 2001;86:2562-2568. (Pubitemid 32545707)
8. Siegel S, Futterweit W, Davies TF, Concepcion ES, Greenberg DA, Villanueva R et al. A C/T single nucleotide polymorphism at the tyrosine kinase domain of the insulin receptor gene is associated with polycystic ovary syndrome. Fertil Steril 2002;78:1240-1243. (Pubitemid 35469148)
9. San Millán JL, Cortón M, Villuendas G, Sancho J, Peral B, Escobar-Morreale HF. Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity. J Clin Endocrinol Metab 2004;89:2640-2646. (Pubitemid 38766343)
10. Diamanti-Kandarakis E, Palioniko G, Alexandraki K, Bergiele A, Koutsouba T, Bartzis M. The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels. Eur J Endocrinol 2004;150:793-798. (Pubitemid 38961652)
11. World Health Organization Obesity: preventing and managing the global epidermic. Report of a WHO consultation on obesity. Geneva: World Health Organization; 1997.
12. Legro RS, Castracane VD, Kaufman R P. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv 2004;59:141-154. (Pubitemid 38140845)
13. Kamel N, Tonyukuk V, Emral R, Corapçioglu D, Bastemir M, Güllü S. Role of ovary and adrenal glands in hyperandrogenemia in patients with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 2005;113:115-121. (Pubitemid 40388783)
14. Geloneze B, Repetto EM, Geloneze SR, Tambascia MA, Ermetice MN. The threshold value for insulin resistance (HOMA-IR) in an admixtured population IR in the Brazilian Metabolic Syndrome Study. Diabetes Res Clin Pract 2006;72:219-220.
15. Katsikis I, Karkanaki A, Misichronis G, Delkos D, Kandaraki EA, Panidis D. Phenotypic expression, body mass index and insulin resistance in relation to LH levels in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2011;156:181-185.
16. Pusalkar M, Meherji P, Gokral J, Chinnaraj S, Maitra A. CYP11A1 and CYP17 promoter polymorphisms associate with hyperandrogenemia in polycystic ovary syndrome. Fertil Steril 2009;92:653-659.
17. Marszalek B, Lacinski M, Babych N, Capla E, Biernacka-Lukanty J, Warenik-Szymankiewicz A et al. Investigations on the genetic polymorphism in the region of CYP17 gene encoding 5′-UTR in patients with polycystic ovarian syndrome. Gynecol Endocrinol 2001;15:123-128. (Pubitemid 32423252)
18. Echiburú B, Pérez-Bravo F, Maliqueo M, Sánchez F, Crisosto N, Sir-Petermann T. Polymorphism T-> C (-34 base pairs) of gene CYP17 promoter in women with polycystic ovary syndrome is associated with increased body weight and insulin resistance: a preliminary study. Metab Clin Exp 2008;57:1765-1771.
19. Petry CJ, Ong KK, Michelmore KF, Artigas S, Wingate DL, Balen AH et al. Association of aromatase (CYP 19) gene variation with features of hyperandrogenism in two populations of young women. Hum Reprod 2005;20:1837-1843. (Pubitemid 40932365)
20. Rani A, Roy AC. Variation in the ERα and ERβ genes and genetic susceptibility to polycystic ovary syndrome. Fertil Steril 2005; 84:S443.
21. Bagos PG. Plasminogen activator inhibitor-1 4G/5G and 5,10-methylene-tetrahydrofolate reductase C677T polymorphisms in polycystic ovary syndrome. Mol Hum Reprod 2009;15:19-26.
22. Karadeniz M, Erdogan M, Berdeli A, Saygili F, Yilmaz C. 4G/5G polymorphism of PAI-1 gene and Alu-repeat I/D polymorphism of TPA gene in Turkish patients with polycystic ovary syndrome. J Assist Reprod Genet 2007;24:412-418. (Pubitemid 47497960)
23. Liu Q, Hong J, Cui B, Zhang Y, Gu W, Chi Z et al. Androgen receptor gene CAG(n) trinucleotide repeats polymorphism in Chinese women with polycystic ovary syndrome. Endocrine 2008;33:165-170.
24. Xita N, Georgiou I, Lazaros L, Psofaki V, Kolios G, Tsatsoulis A. The synergistic efect of sex hormone-binding globulin and aromatase genes on polycystic ovary syndrome phenotype. Eur J Endocrinol 2008;158:861-865. (Pubitemid 351837375)
25. Hickey T, Chandy A, Norman RJ. The androgen receptor CAG repeat polymorphism and X-chromosome inactivation in Australian Caucasian women with infertility related to polycystic ovary syndrome. J Clin Endocrinol Metab 2002;87:161-165. (Pubitemid 34084686)
26. Kim JJ, Choung SH, Choi YM, Yoon SH, Kim SH, Moon SY. Androgen receptor gene CAG repeat polymorphism in women with polycystic ovary syndrome. Fertil Steril 2008;90:2318-2323.
27. Xita N, Tsatsoulis A. Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies. J Clin Endocrinol Metab 2006;91: 1660-1666.
28. Simoni M, Tempfer CB, Destenaves B, Fauser BC. Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response. Hum Reprod Update 2008;14:459-484.
29. Chen ZJ, Zhao H, He L, Shi Y, Qin Y, Shi Y et al. Genome-wide association study identifes susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet 2011;43:55-59.